tiprankstipranks
Anika Therapeutics (ANIK)
NASDAQ:ANIK
US Market
ANIK
Anika Therapeutics
RESEARCH TOOLSreports

Anika Therapeutics (ANIK) Income Statement

176 Followers

Anika Therapeutics Income Statement

Last quarter (Q4 2025), Anika Therapeutics's total revenue was $30.61M, a decrease of -2473.26% from the same quarter last year. In Q4, Anika Therapeutics's net income was $292.00K. See Anika Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 112.82M$ 119.91M$ 120.79M$ 113.83M$ 147.79M
Gross Profit
$ 63.81M$ 76.00M$ 82.53M$ 73.22M$ 82.94M
Operating Expenses
$ 74.86M$ 81.10M$ 81.69M$ 69.55M$ 80.33M
Depreciation and Amortization
$ 5.73M$ 8.12M$ 14.22M$ 14.49M$ 14.32M
EBITDA
$ -1.83M$ 3.02M$ 15.06M$ 18.16M$ -4.16M
Operating Income
$ -11.05M$ -5.10M$ 844.00K$ 3.67M$ 2.62M
Other Income/Expenses
$ 1.74M$ 2.34M$ 2.31M$ 654.00K$ -188.00K
Pretax Income
$ -9.31M$ -2.76M$ 3.16M$ 4.32M$ 2.43M
Net Income
$ -10.88M$ -56.38M$ -82.67M$ -14.86M$ 4.13M
Per Share Metrics
Basic EPS
$ -0.76$ -3.83$ -5.64$ -1.02$ 0.29
Diluted EPS
$ -0.76$ -3.83$ -5.64$ -1.02$ 0.28
Weighted Average Shares Outstanding
 14.34M 14.72M 14.66M 14.56M 14.40M
Weighted Average Shares Outstanding (Diluted)
 14.34M 14.72M 14.66M 14.56M 14.63M
Currency in USD

Anika Therapeutics Earnings and Revenue History